Research any topic before you write.

Find related topics. | Discover entities. | See connections. | Build a topical map.

Ecopipam: Research & Standards

Ecopipam (development codes SCH-39166, EBS-101, and PSYRX-101) is a dopamine antagonist which is under development for the treatment of Lesch–Nyhan syndrome, Tourette syndrome, speech disorders, and restless legs syndrome. It is taken by mouth.

Language: English [EN]
Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.
100%
More settings
100% 100% 100% 100% 100%

Ecopipam topic overview

The analysis highlights Research and Standards as prominent areas in the source structure around Ecopipam.

Related topics
64
Source areas
4
Connected nodes
68
Extracted relationships
27
Related term clusters
30
Bridge connections
68

What this topic covers Research coverage

Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.

Overview · 31 topics
Research · 25 topics
Chemistry · 5 topics
Pharmacology · 3 topics

Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.

Key facts & relationships

High-confidence facts extracted from structured source data. Use them as anchors for further research.

3D model (JSmol)
Interactive image
ATC code
none
CAS Number
112108-01-7 Y
ChemSpider
97053
CompTox Dashboard (EPA)
DTXSID8043814
Elimination half-life
10 hours

Start with your topic. Discover where to go next.

Explore different angles and find fresh ideas to shape your next piece of content.

Explore all related topics Closing gaps

Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.

Overview

Pharmacology

Research

Chemistry

For the semantics nerds

You can skip this section if you’re here for content ideas and keyword inspiration.

Advanced semantic analysis

How Ecopipam connects Entity context

The extracted context around Ecopipam shows recurring relationship patterns in the source. For example, Ecopipam → Based, D2, Human, Open-label, Parkinsonian-like, Side Another extracted example is Ecopipam → D1, D2-like, D5, HT2. Use these groups to spot repeated connection types before inspecting the individual relationships.

Ecopipam

Top relations

related to Research · 6
Ecopipam → Based, D2, Human, Open-label, Parkinsonian-like, Side
related to Pharmacodynamics · 4
Ecopipam → D1, D2-like, D5, HT2
is a · 2
Ecopipam → experimental drug and has not been approved for medical use, synthetic benzazepine derivative
3D model (JSmol) · 1
Ecopipam → Interactive image
ATC code · 1
Ecopipam → none
CAS Number · 1
Ecopipam → 112108-01-7 Y
ChemSpider · 1
Ecopipam → 97053
CompTox Dashboard (EPA) · 1
Ecopipam → DTXSID8043814
Elimination half-life · 1
Ecopipam → 10 hours
Formula · 1
Ecopipam → C19H20ClNO

Important terminology

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

dopamine syndrome treatment antagonist receptor tourette effects drug disorders also development restless legs d1 anxiety receptors side d2 antagonists use

Ecopipam relationships Subject–Predicate–Object triples

TTTA extracted 27 structured relationships around Ecopipam. Examples in this analysis include Ecopipam → 3D model (JSmol) → Interactive image and Ecopipam → ATC code → none. The table shows each extracted connection, where it came from and its confidence.

SubjectPredicateObjectConfidenceSrc
Ecopipam3D model (JSmol)Interactive image1.00infobox
EcopipamATC codenone1.00infobox
EcopipamCAS Number112108-01-7 Y1.00infobox
EcopipamChemSpider970531.00infobox
EcopipamCompTox Dashboard (EPA)DTXSID80438141.00infobox
EcopipamElimination half-life10 hours1.00infobox
EcopipamFormulaC19H20ClNO1.00infobox
EcopipamIUPHAR/BPS33041.00infobox
EcopipamLegal statusInvestigational1.00infobox
EcopipamMolar mass313.83 g·mol−11.00infobox
EcopipamOther namesEBS-101; PSYRX-101; SCH-391661.00infobox
EcopipamPubChem CID1079301.00infobox
EcopipamRoutes of administrationBy mouth1.00infobox
EcopipamUNII0X748O646K1.00infobox
Ecopipamis aexperimental drug and has not been approved for medical use0.90text
Ecopipamis asynthetic benzazepine derivative0.90text

Related concept clusters Related term clusters

The concept neighborhoods around Ecopipam bring nearby vocabulary together. In this analysis, examples include Treatment, Syndrome and Antagonist. Use the clusters to find adjacent concepts and terminology that may deserve separate research.

  • Ecopipam
    • Treatment
    • Syndrome
    • Antagonist
    • Clinical
    • Found
    • Studies
    • Legs
    • Receptor
    • Restless
    • Also
    • Effects
    • Tourette
  • ecopipam
    • Treatment
    • Syndrome
    • Antagonist
    • Clinical
    • Found
    • Studies
    • Legs
    • Receptor
    • Restless
    • Also
    • Effects
    • Tourette
  • dopamine antagonist
    • D1
    • D5
    • Ebs-101
    • Psyrx-101
    • Receptors
    • Sch-39166
    • Selective
    • Antagonist
    • Dopamine
    • Elimination
    • Half-life
    • Hours
  • antagonist
    • D5
    • Ebs-101
    • Psyrx-101
    • Sch-39166
    • Selective
    • Dopamine
    • D1
    • Receptor
    • Also
    • Ecopipam
    • Elimination
    • Half-life
  • dopamine
    • D1
    • Receptors
    • Antagonist
    • D5
    • Ebs-101
    • Elimination
    • Half-life
    • Hours
    • Psyrx-101
    • Sch-39166
    • Selective
    • Receptor
  • food and drug administration
    • Also
    • D5
    • Ebs-101
    • Elimination
    • Half-life
    • Hours
    • Mouth
    • Psyrx-101
    • Sch-39166
    • Selective
    • D1
    • Treatment
  • speech disorders
    • Speech
    • Tourette
    • Legs
    • Restless
    • Syndrome
    • Treatment
    • Ebs-101
    • Obesity
    • Psyrx-101
    • Sch-39166
    • Schizophrenia
    • Use
  • cocaine-related disorders
    • Speech
    • Legs
    • Restless
    • Tourette
    • Treatment
    • Ebs-101
    • Obesity
    • Psyrx-101
    • Sch-39166
    • Schizophrenia
    • Syndrome
    • Use

Connections between topic areas Semantic bridges

For Ecopipam, one of the stronger structural bridges in this analysis connects Ecopipam with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.

Min side: 3
Ecopipam — Overview · splits 37 ⟂ 32
Ecopipam — Research · splits 43 ⟂ 26
Ecopipam — Chemistry · splits 63 ⟂ 6
Ecopipam — Pharmacology · splits 65 ⟂ 4

Map overview Semantic statistics

Ecopipam

Nodes69
Edges68
Triples27
Avg. degree1.97
Density0.028986
Components1

Source & methodology

TTTA analyzes the structure around Ecopipam to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Research & Standards, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.

Source: Wikipedia — Ecopipam · EN edition · Analysis: TopicsToTalkAbout

For writers, content strategists, SEOs, marketers and creators — from quick topic research to advanced semantic analysis.

Monitor your Domain Rating with FrogDR